Biomarkers for assessment of intestinal permeability in clinical practice
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
This study shows that biomarkers from blood and fecal samples are associated with the cumbersome established tests of intestinal permeability throughout different cohorts. Therefore, such biomarkers could be used to assess gut barrier function in prospective cohort studies and large-scale clinical trials for which tracer-based tests may not be feasible.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adaptive linear step-up procedures that control the false discovery rate
Benjamini, Y., Krieger, A. M., & Yekutieli, D. (2006) · Biometrika · doi:10.1093/biomet/93.3.491 · Cited by 3,228 · cited 1×
“Multiple testing was adjusted with a false discovery rate of 10% according to Benjamini et al. (17).”
Intestinal permeability – a new target for disease prevention and therapy
Bischoff, S. C., Barbara, G., Buurman, W., Ockhuizen, T., Schulzke, J.-D., Serino, M., Tilg, H., Watson, A., & Wells, J. M. (2014) · BMC Gastroenterology · doi:10.1186/s12876-014-0189-7 · Cited by 1,755 · cited 3×
“Intestinal permeability is a diagnostic measure of intestinal barrier integrity and is frequently used to assess intestinal mucosal injury in several disorders, including Crohn ’ s disease and celiac disease (1, 2).”
Self-citationStructure and Function of Lipopolysaccharide Binding Protein
Schumann, R. R., Leong, S. R., Flaggs, G. W., Gray, P. W., Wright, S. D., Mathison, J. C., Tobias, P. S., & Ulevitch, R. J. (1990) · Science · doi:10.1126/science.2402637 · Cited by 1,672 · cited 2×
“It should be considered, however, that not only LPS translocation from the intestine but also other factors like bacterial infection can increase circulating LBP (9).”
Leaky gut: mechanisms, measurement and clinical implications in humans
Camilleri, M. (2019) · Gut · doi:10.1136/gutjnl-2019-318427 · Cited by 1,081 · cited 2×
“Intestinal permeability is a diagnostic measure of intestinal barrier integrity and is frequently used to assess intestinal mucosal injury in several disorders, including Crohn ’ s disease and celiac disease (1, 2).”
Fasano, A., Not, T., Wang, W., Uzzau, S., Berti, I., Tommasini, A., & Goldblum, S. E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02169-3 · Cited by 670 · cited 1×
“Zonulin is an acute-phase reaction protein that controls intestinal permeability by decreasing the stability of tight junctions (11) and has been suggested as a biomarker of intestinal permeability (11, 12), which can be measured in both blood and fecal samples.”
Homeostasis of the gut barrier and potential biomarkers
Wells, J. M., Brummer, R. J., Derrien, M., MacDonald, T. T., Troost, F., Cani, P. D., Theodorou, V., Dekker, J., Méheust, A., de Vos, W. M., et al. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00048.2015 · Cited by 620 · cited 2×
“Therefore, circulating I-FABP may re fl ect translocation from the gut into the bloodstream and has been suggested as a biomarker of intestinal permeability (15).”
Sapone, A., de Magistris, L., Pietzak, M., Clemente, M. G., Tripathi, A., Cucca, F., Lampis, R., Kryszak, D., Cartenì, M., Generoso, M., et al. (2006) · Diabetes · doi:10.2337/db05-1593 · Cited by 543 · cited 1×
“Zonulin is an acute-phase reaction protein that controls intestinal permeability by decreasing the stability of tight junctions (11) and has been suggested as a biomarker of intestinal permeability (11, 12), which can be measured in both blood and fecal samples.”
Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis
Tajik, N., Frech, M., Schulz, O., Schälter, F., Lucas, S., Azizov, V., Dürholz, K., Steffen, F., Omata, Y., Rings, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15831-7 · Cited by 492 · cited 1×
“The failure of plasma zonulin as a barrier marker according to our study might be related to the limited speci fi city of the human ELISA kits, as described below in more detail, whereas mouse data seem to be more consistent (18).”
Self-citationOckner, R. K., & Manning, J. A. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107768 · Cited by 471 · cited 1×
“Intestinal fatty acid binding protein (I-FABP; also known as fatty acid binding protein 2) is a cytosolic protein which plays a key role in the cellular uptake and metabolism of fatty acids in enterocytes and is released into the gut lumen in cases of injury (13).”
Human zonulin, a potential modulator of intestinal tight junctions
Wang, W., Uzzau, S., Goldblum, S. E., & Fasano, A. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.24.4435 · Cited by 470
Cited by
Seethaler, B., Nguyen, N. K., Basrai, M., Kiechle, M., Walter, J., Delzenne, N. M., & Bischoff, S. C. (2022) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac175 · Cited by 179
Self-citationDumitrescu, L., Marta, D., Dănău, A., Lefter, A., Tulbă, D., Cozma, L., Manole, E., Gherghiceanu, M., Ceafalan, L. C., & Popescu, B. O. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.689723 · Cited by 100
Wasiak, J., & Gawlik-Kotelnicka, O. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114459 · Cited by 47
Bar, S., Hilsabeck, T. A. U., Pattavina, B., López-Domínguez, J. A., Basisty, N., Bons, J., Watson, M., Schilling, B., Campisi, J., Kapahi, P., et al. (2025) · Aging · doi:10.18632/aging.206224 · Cited by 3
Metadata
- Authors
- Seethaler, B., Basrai, M., Neyrinck, A. M., Nazare, J.-A., Walter, J., Delzenne, N. M., & Bischoff, S. C.
- Venue
- American Journal of Physiology-Gastrointestinal and Liver Physiology
- Publisher
- American Physiological Society
- Published
- 2021-07-01
- Volume
- 321
- Issue
- 1
- Pages
- G11-G17
- ISSN
- 0193-1857 (ISSN-L)
- 1522-1547
- OpenAlex
- W3163722927
- Cited by
- 249
- References
- 32
- FWCI
- 25.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Biomarkers for assessment of intestinal permeability in clinical practice. https://app.cochat.ai/papers/10.1152/ajpgi.00113.2021
- The paper
- Seethaler, B., Basrai, M., Neyrinck, A. M., Nazare, J.-A., Walter, J., Delzenne, N. M., & Bischoff, S. C. (2021). Biomarkers for assessment of intestinal permeability in clinical practice. American Journal of Physiology-Gastrointestinal and Liver Physiology. https://doi.org/10.1152/ajpgi.00113.2021
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.